CIK 0001817229 · <br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Open-market sale 10% owner sold 447,278 shares at $1.54 ($688,853)
- 4 Open-market sale 10% owner sold 984,805 shares at an average $1.73 ($1,703,971)
- 4 Open-market sale 10% owner sold 1,263,647 shares at an average $1.95 ($2,457,975)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 1,407,628 shares at an average $1.97 ($2,767,982)
- 4 Open-market sale 10% owner sold 1,417,998 shares at an average $2.01 ($2,848,511)
- 4 Open-market sale 10% owner sold 671,536 shares at an average $2.10 ($1,411,083)
- 4 Grant or award Chief Development Officer acquired 937,080 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO acquired 13,882,750 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 11 · 212 filings